Matt is an M&A transaction specialist with 14 years’ experience including 4 years in Deloitte’s transactions and restructuring team, 3 years executing highly structured deals at Barclays Capital, and 4 years originating and executing deals at boutique M&A advisory Corbett Keeling. 

Educationally, qualified as a chartered accountant whilst at Deloitte, qualified as an associate of the CISI whilst at Barclays Capital, and registered as a Financial Conduct Authority approved person whilst at Corbett Keeling.

Matt’s core skillset includes marketing businesses, negotiation, and transaction structuring. He has been focused on the technology and science-driven chemicals markets for the last 7 years.

Steve has a wide-ranging network throughout the chemical industry and a strong track record of sourcing C-Suite personnel to fill corporate development roles.

Steve holds an MSc in Bio/analytical chemistry and an MBA. Starting as a chemicals equity analyst for UBS Warburg, he worked for 9 years at Air Products in corporate development and business management.

He founded Chemical Search International in 2000, a leading global specialist executive search firm focused on the chemicals sector and now heads up CCD Partners' Talent function.

Peter is highly connected and well-known in mid and small-scale chemical business circles, particularly in Europe and the US, and has an unparalleled strategic overview of the myriad niche market segments of the industry. 

Peter started off securing a PhD in biochemistry/pharmacology from Cambridge before going on to a variety of increasingly senior roles across many sectors at ICI over a 13 year period, with a 2 year stint at PA Consulting. 

Baring Brothers head-hunted Peter to establish their global chemicals practice, a role he stayed in for 10 years before branching out on his own for a further 14 years, focusing more on the technology and science-driven chemicals markets.

Gunnar has extensive commercial experience with pharmaceutical companies as well as Contract Research Organisations (CROs). He held various positions at Eli Lilly, Novartis, and Astellas before joining Serentis, a biotech in Cambridge UK, as Commercial Director.

In 2009 Gunnar joined Avantium as CEO of Avantium Pharma their troubled pharmaceutical CRO business specialising in solid state research. He executed a management buyout of Avantium Pharma and as CEO implemented a turnaround plan taking the new company Crystallics from a loss making business to a successful global service provider for the pharmaceutical industry and five years later sold the business to Ardena (www.ardena.com).

He received a MBA from Warwick Business School and an undergraduate Economics degree from the University of Reading.

Adele-Marie read Maths at Durham University before qualifiying as an accountant with Ernst & Young's audit team.

She worked as an accountant and internal auditor at RAB Capital and MAN Investments before becoming an Assistant Director at the UK's Competition and Markets Authority, a role that involved financial and markets analysis in relation to proposed M&A deals.

Adele-Marie now heads up CCD Partners' finance and treasury function.

Matthew Wise

Head of Data

Matthew graduated from the University of York with a first in biological sciences, specialising in biotech and genetic engineering and then went on to secure a master’s in finance (including financial modelling, equity valuation, and corporate finance) from the University of Edinburgh. 

He gained real-world experience in data analysis, strict deadlines, and high-pressure decision-making as an FX trader before joining the CCD Partners team supporting the M&A and strategic advisory functions.

Basil Saeed

Associate Partner

Basil holds a BSc in Biochemistry from King’s College London and an MSc in International Business from Hult Business School. Prior to joining CCD Partners, he served as a strategy & growth consultant and board observer for a multinational business conglomerate, where he was responsible for conducting both financial and strategic analysis to identify areas of long-term growth and expansion. 

His experience in corporate development and strategy was gained across numerous industries, enabling him to lead multiple, cross-functional business departments. Basil now supports CCD Partners' M&A and strategic advisory functions.

Kai Alexander

Senior Analyst

Kai holds a MS in Pharmacy from the University of Brighton, specialising in Clinical and Pharmaceutical Science, with a minor in Business and Economics. He is also a qualified pharmacist.

He later gained valuable experience interning at HSBC’s Corporate Banking division and Deloitte’s Banking & Capital Market Operations division. Kai now supports CCD Partners' M&A and strategic advisory functions.

Outside of work, Kai is a keen sportsman who enjoys rugby, mixed martial arts, tennis, and can occasionally be found on the ski slopes.